Benzinga | May 10, 2021 07:18AM EDT

Amicus Therapeutics Q1 EPS $(0.25) Misses $(0.24) Estimate, Sales $66.40M Miss $71.65M Estimate

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 28.57 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $66.40 million which missed the analyst consensus estimate of $71.65 million by 7.33 percent. This is a 9.71 percent increase over sales of $60.52 million the same period last year.